IB
CLB icon

Intrust Bank’s Core Laboratories CLB Stock Holding History

Intrust Bank’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,366
Closed -$442K – 367
2017
Q2 		$442K Buy
4,366
+1,075
+33% +$116K 0.15% 192
2017
Q1 		$380K Buy
3,291
+473
+17% +$55K 0.13% 237
2016
Q4 		$339K Buy
2,818
+228
+9% +$25.2K 0.13% 244
2016
Q3 		$291K Buy
2,590
+227
+10% +$26.1K 0.12% 269
2016
Q2 		$293K Sell
2,363
-709
-23% -$85.6K 0.12% 254
2016
Q1 		$345K Buy
3,072
+619
+25% +$64.3K 0.12% 202
2015
Q4 		$267K Buy
2,453
+145
+6% +$16.6K 0.1% 227
2015
Q3 		$230K Buy
2,308
+50
+2% +$5.44K 0.09% 235
2015
Q2 		$258K Sell
2,258
-167
-7% -$20.3K 0.09% 238
2015
Q1 		$253K Buy
2,425
+638
+36% +$68K 0.09% 230
2014
Q4 		$215K Buy
+1,787
New +$235K 0.08% 252

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Intrust Bank's CLB Position: Q3 2017 in Review

Intrust Bank sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 4,366 shares — an estimated $442K sold.

Intrust Bank first reported a position in CLB in Q4 2014 and held it in 11 quarters. The position peaked at $442K in Q2 2017. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Intrust Bank reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Intrust Bank sold 4,366 Core Laboratories shares in Q3 2017, an estimated $442K.
  • Intrust Bank first reported a position in Core Laboratories in Q4 2014 and held it in 11 quarters.
  • Intrust Bank's Core Laboratories position peaked at $442K in Q2 2017.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Intrust Bank's 13F filing for Q3 2017, filed 6 Nov 2017.